Q3 2019 Investor Conference Call

Wednesday, October 30, 2019
Start at approx. 2:00 p.m. CET (1:00 p.m. UTC)

Investor News October 30, 2019

Third quarter of 2019

Bayer: Encouraging business performance across all divisions - agreements signed to divest Currenta and Animal Health

Group sales increase by 5.4 percent (Fx & portfolio adj.) to 9.830 billion euros / EBITDA before special items advances by 7.5 percent to 2.291 billion euros / Crop Science reports higher sales and substantial earnings growth / Pharmaceuticals increases sales - earnings decline due to one-time income in prior year / Consumer Health posts growth in sales (Fx & portfolio adj.) and earnings / Net income declines by 63.9 percent to 1.036 billion euros - substantial divestment gain included in prior year / Core earnings per share up by 6.4 percent to 1.16 euros / Group outlook confirmed and aligned to continuing operations MORE